Erlotinib Impurity 26 | CAS 115-19-5 - Request Quote
Erlotinib Impurity 26
| SZ CAT No: | SZ-E018043 |
| CAS No | 115-19-5 |
| Mol.F. | C5H8O |
| Mol.Wt. | 84.1 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Erlotinib Impurity 26 is chemically 2-Methyl-3-butyn-2-ol ; (1-Hydroxy-1-methylethyl)acetylene ; 1,1-Dimethyl-2-propyn-1-ol ; 2-Methyl-2-hydroxy-3-butyne ; 3-Methyl-3-hydroxy-1-butyne. Erlotinib Impurity 26 is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Impurity 26 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 115-19-5
Purchase 115-19-5
Order 115-19-5
Enquire 115-19-5
price of 115-19-5
115-19-5 Supplier
115-19-5 Manufacturer
115-19-5 Exporter
buy high quality Erlotinib Impurity 26
Purchase Erlotinib Impurity 26
Erlotinib Impurity 26 suppliers
Erlotinib Impurity 26 manufacturers
Erlotinib Impurity 26 price
Order Erlotinib Impurity 26
Enquire Erlotinib Impurity 26
Erlotinib Impurity 26 cost
Erlotinib Impurity 26 Supplier
Erlotinib Impurity 26 Distributor
Erlotinib Impurity 26 for Method Validation
Erlotinib Reference Standard
Erlotinib Impurity 26 for ANDA Filing
Erlotinib Impurity 26 for Forced Degradation Studies
Erlotinib Impurity 26 Identification Standards
Erlotinib Impurity 26 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


